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SYNTHESIS AND BIOLOGICAL ACTIVITY OF FOUR 
ANALOGUES OF 0-CORTICOTROPIN*
BY
G. I. TESSER and J. T. BUIS
(D epartm ent o f Organic Chem istry, R. C. U niversity , Nijmegen, T he N etherlands)
T he syntheses o f four A C TH -analogues: [O m 15-18]-, [D-Ser', O m 15-18]-, 
[O m 11,15-18]- and [D-Ser1, O rn 1 1 1 5 _18]-/3-corticotropin-( 1 - 1 8)-octadecapeptide 
amide** are described. T he last m entioned com pound exhibits an unexpected, 
strongly prolonged, biological activity. A possible explanation is given.
In previous investigations it has been shown that the arginine residues 
in positions 17 and 18 of the natural sequence of ACTH can be sub- 
stituted by ornithine without loss in potency. [Orn17,18]-/3-corticotropin- 
(l-24)-tetracosapeptide is as potent in vitro and in vivo as the un- 
modified tetracosapeptide1. Since the diornithine analogue is more readily 
synthesized than the original diarginine polypeptide, a similar substitu- 
tion was carried out with respect to the remaining arginine residue in 
position 8. However, in vivo adreno-corticotropic activity of [Om8] — as 
well as [Orn8,17,18]-/3-corticotropin-(l-24)-tetracosapeptide — appeared to 
be reduced to about 1% of that of the “natural” tetracosapeptide2.
As the nature o f the basic amino acids 17 and 18 in the natural 
sequence L ys-L ys-A rg-A rg (positions 15 to 18), which ha’s long been  
regarded as a binding site3, appears not critical (a [Lys17,18]-analogue 
also has proved to be fully active4), it seemed appropriate to investigate 
the influence of further substitutions in which the lysine residues 15 and 
16, and even 11 are also replaced by ornithine.
An inducement for investigating such substitutions is that the suscepti- 
bility of basic amino acid derivatives towards tryptic hydrolysis depends 
strongly on the length of the side chain bearing the positive charge;
* N om enclature o f P. H . Bell, J. Am. Chem. Soc. 76,5565 (1954). A ccording to C. H . L i, 
Science 129,969 (1959) the com pound should be named a-adrenocorticotropin.
** D esignation and abbreviation according to  the 1UPAC-1UB Com m ission on  Biological 
Nom enclature, Biochem istry 6 ,3 6 2  ( 1967).
1 C . /. Tesser and R .S ch w yzer , Helv. Chim. A cta49 , 1013(1966).
2  G . /. Tesser  and W. R ittel, Rec. T rav. Chim. 8 8 , 553 (1969).
3  K . H ofm ann , Brookhaven Symp. Biol. 13, 184 (1960).
4  B. R iniker  and W. R ittel, Helv. Chim. A cta  53,513 (1970).
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hydrolysis of ornithyl derivatives by trypsin is very slow in comparison 
with corresponding arginyl or lysyl derivatives5-7.
With a simple pH-stat technique8 we found that phthaloyl-glycyl-L- 
ornithine methyl ester hydrochloride (II), in the concentration range 
where zero order kinetics are followed, hydrolyzes about 20 times slower 
than its lysine analogue, I, under the influence of trypsin (Fig. 1).
Fig. 1. Velocity o f trypsin-catalyzed hydrolysis o f an om ithine ester (II) relative to  its 
lysine analogue (I). D o tted  lines represent production o f acid, due to  spontaneous hydroly­
sis (for I and II) and lactam  form ation (for II).
If, therefore, substitution of lysine residues in corticotrophic peptides 
by omithine should not substantially reduce biological potency, an 
expected increase in stability might eventually lead to prolonged activity. 
For that reason, in the evaluation of corticotrophic properties of the new 
analogues investigated, special attention was paid to the duration of 
steroidogenesis, using a method described by Dessaulles and R ittel9.
5  E. B rand , A . A . P lentl and B. F. Erlanger, Abstr. Pap. Am. Chem. Soc., 116th Meeting, 
A tlantic C ity, p. 27C  (1949).
6  N . Izum iya, T. O kazaki, 1. M atsum oto  and H . Takiguchi,S . Biochem. 46, 1377 (1959).
7  N .J .  B a in es,J . B . B a ird a n d D . T .E lm ore , Biochem. J. 90 ,470  (1964).
8  G. I. T esser , R .J .  F. N ivard  and M . Gruber, Bioch. Bioph. A cta89 , 303 (1964).
9  P. A . Dessaulles and W. R itte l , Mem. Soc. Endocrin. 17, 125 (1968).; Eds. V. H . F. 
Jam es  and 7. Landon, Cambridge.
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Because the shortest fragment of ACTH which displays full biological 
activity is the octadecapeptide having the amino terminal sequence 
(1 -1 8)10*11, analogues of this peptide have been synthesized and tested. 
Generally, the activity of short, amino terminal ACTH fragments is 
enhanced by terminating the chain with an amide group11. This has also 
been done in this investigation (Fig. 2).
Ser-T yr-Ser-M et-Glu-His-Phe-Arg-T rp-GIy-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg (A) 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Ser-Tyr~Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-VaI~GIy~0ra~0m-On~0m~NH2 (B)
D-Ser-Tyr-Ser-Met~Glu-His-Phe-Arg-Trp-Gly-Lys-Pro~Val~Gly~C>ra-Ora~Ora-Ora-NH2 (C)
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-GIy-0/7z-Pro-Val-GIy-Ora-Orrt-Om-Ora-NH2 (D)
D-5e/'-Tyr-Ser-M et-Glu-His-Phe-Arg-Trp-Gly-Or«-Pro-Val-Gly-Om-Om-Om-Or«-NH2 (E)
Fig. 2. N atural sequence 1-18 of corticotropin (A) and analogues investigated (B -E).
It has been shown9 that substitution of the unnatural D-serine for 
L-serine in position 1 doublés the duration of steroidogenesis following 
subcutaneous injection (into rats) of a tetracosapeptide containing the 
natural sequence.
A similar substitution in [Orn17'18]-/3-corticotropin-(l-24)-tetracosa- 
peptide causes an even more pronounced prolongation of activity9. 
Therefore, compounds C and E (fig. 2) have also been prepared and 
tested.
Synthetic design
The syntheses of two fully protected octapeptide amides, representing 
the carboxyl terminal parts of compounds B (and C) and D (and E) 
respectively, is shown in scheme I. They were obtained from the pro­
tected tetrapeptides (X lla  and b) bearing a lysyl or an ornithyl group as 
yV-terminal amino acid and the partially protected tetrapeptide ester 
IX, by condensation with dicyclohexylcarbodiimide.
The fully protected tetrapeptide ester VIII was obtained from the 
ornithyl ornithine derivatives VI and VII by the method of W eygand  
and Wünsch12, in which racemization is completely suppressed by virtue 
of a low reaction temperature and the addition of N-hydroxysuccinimide.
The final conversion of the esters X lIIa  and X lIIb  into amides was 
effected with methanolic ammonia. The reactions were slow, and the 
end-products, although crystalline, had to be purified by counter-currerit 
distribution.
1 0  R . Schw yzer , Ann. Rev. Biochem. 33 ,259  (1964).
1 1 J. R am achandran, D. Chung  and C. H . Li, J. Am. Chem. Soc. 87,2696 (1965).
1 2 F. W eygand, D . H offm ann  and E. W ünsch, Z . N aturforsch. 21b, 426 (1966).
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Scheme I
For the preparation of compounds (B-E) (scheme II) the amides 
X IV a and X lV b  were hydrogenolyzed in a slightly acidic medium. The 
resulting hydrochlorides XVa and XVb were coupled with the appro- 
priate protected decapeptides X V Ia and XVIb13, using dicyclohexyl- 
carbodiimide as the condensing agent without an additional equivalent 
of base.
After counter-current distribution the protected octadecapeptides 
X V IIa-d  were obtained in the acetate form in yields of 50-70%.
13  R . Schw yrer and W. R ittel, Helv. Chim. A c ta 4 4 ,159 (1961).
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Schem e II
Removal of protecting groups with 90% trifluoroacetic acid, and ex- 
change of trifluoroacetate by acetate ions through filtration through a 
short column of weakly basic ion exchanger in the acetate form was 
performed with quantitative yield.
Biological Activity*
Results of activity measurements, represented in Table I and Fig. 3, 
reveal that all compounds (B-E) show corticotrophic activity. With 
compounds B and D , in which 4 or 5 basic amino acids (lysine and argin- 
ine) have been replaced by ornithine the adrenal steroid excretion, half 
an hour after subcutaneous injection, is comparable with that of an equal 
dose of the refèrence compound (A). Ho wever, duration of steroido- 
genesis is substantially decreased.
Inversion of the configuration of the /V-terminal serine residue pro- 
longs the duration of activity of both compounds B and D  about four- 
fold. In comparison with the Standard A, compound E in particular 
produces a strongly protracted steroidogenesis.
Our results confirm that inversion of configuration of the serine residue
* Biological activities were determ ined at the Biological R esearch Laboratories, Pharm a- 
ceutical Division, C iba Ltd., Basel, Switzerland. We are greatly indebted to D r. P. A . 
D essaulles  and D r. R . M aier  for perform ing the tests.
T ab le  I
Plasm a corticosterone concentration (/u.g/100 ml) following subcutaneous application of A C T H  analogues (0.3 
mg/kg body weight) in rats that wère hypophysectom ized 24 h previously (compare ref. 9).
Com pound
N um ber
of
animals J h 1 h l i h 2  h 4 h 6  h 8  h
A /3-Corticotropin( 1-24) 
tetracosapeptide 18 30.3 ± 2 .5 30.2 ± 2 .5 14.3 ± 2 .9 1.7 ±  1.7 < 1 < 1 <  1
B [Orn1 5_1 8]-/3-Cort.-( 1-18)- 
octadecapeptide amide 3 29.5 ± 2 .1 < 1 < 1 < 1 < 1 < 1 <  1
C [D-Ser1, O rn15_18]-j8-Cort.-(l-18) 
octadecapeptide amide 3 1 7 .2± 2 .0 20.4 ± 1 .7 20.4 ± 5 .3 16.8 ± 6 . 2 < 1 < 1 < 1
D [O m 1 1-1 5_18]-/3-Cort.-( 1-18)- 
octadecapeptide amide 3 25.0 ± 2 .7 7 .2 ± 0 .6 < 1 < 1 < 1 < 1 < 1
E [D-Ser1, O ra 1 1 ,I5_1 8]-j8 -Cort.-( 1-18)- 
octadecapeptide amide 3 29.7 ± 6 . 8 29.9 ± 2 .8 28.1 ± 0 .9 2 5 .4 ± 2 .2 1 5 .0± 2 .4 < 1 < 1
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Fig. 3. A drenocortical response to the subcutaneous injection of one single dose o f the 
analogues B -E  in hypophysectom ized rats, com pared with the effect elicited by the same 
dose of the aminoterm inal tetracosapeptide o f /3 -corticotropin (A).
in position 1 in ACTH analogues always leads to prolonged activity, 
which may be caused by hampered hydrolysis by aminopeptidases.
Substitution of ornithine for lysine in position 11 (D versus B, and 
E versus C) seems to have a similar, but smaller effect. It needs further 
studies to determine whether or not the lysyl-prolyl bond (positions 11- 
12) is a second point of attack in the enzymic degradation of cortico- 
tropins in vivo.
Substitution of lysine and arginine residues in the strongly basic part 
(15-18) by ornithine does not abolish biological activity. However, 
simultaneous exchange of all of them leads to analogues with reduced 
and especially shortened activity.
Experimental part
M elting points w ere determ ined with a  H eiztisch M icroscope (Leitz) and are uncorrected. 
Specific rotations were m easured with a Z eiss-W inkel Polarim eter. C ounter-current dis- 
tributions w ere carried out with an instrum ent from  L abortec (Basel).
In  thin layer chrom atography on silica (TS), Kieselgel G  (Merck) was used predomin- 
antly with benzene-acetone (B e-A n) o r chloroform -m ethanol m ixtures in the proportions
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specified fo r each case as solvent systems. In T L C  on alum ina covered plates (TA) the 
system s 52: n-butanol-acetic  acid -w ater (1 0 0 :1 0 :3 0 ), 52A: n-butanol-acetic  acid-w ater 
(1 0 0 :1 5 :3 4 ) o r 101B: n-butanol-pyrid ine-acetic  acid -w ater (4 0 :2 4 :6 :3 0 )  w ere used.
Schem e 1.
Z-O rn(B oc)-O M e (II)
9.15 g (25 mmoles) o f Z-Orn(Boc)-O H (I ) 1 were added to an ethereal solution of diazo- 
m ethane containing a small excess o f the reagent. -After the evolution of nitrogen had 
ceased the  reaction m ixture was kept at room tem perature for two hours and residual 
diazom ethane was destroyed by dropwise addition o f glacial acetic acid. T he solution was 
then  evaporated to dryness leaving the m ethyl ester in theoretical yield. T he white solid 
was purified by crystallization from  ether-petro leum  ether ( 1 : 2 ) o r from  diisopropyl ether. 
M.p. 71°; [a]D27° =  —14.4° (c =  1.08 in 90% A cO H ); TS: f l , =  0.69, B e^A n (1 :1); 0.83, 
C H C l3-M e O H  (4:1).
Analysis: C 1 9H 2 8 N 2 0 6  Calcd. C59.98 H 7.42 N  7.36 
(380.43) Found C 60.0 H 7 .3  N  7.3
P h t-G ly -O rn (B o c )-O M e
3.8 g (10 mmoles) of the  foregoing ester II  were dissolved in 20 ml 90%  acetic acid and 
hydrogenated in the presence of 50 mg of palladium on charcoal (10%). A fter söme min- 
utes the uptake of hydrogen ceased when 245 ml had been absorbed. T he suspension was 
filtered and the filtrate evaporated to  dryness. The residue was dried briefly a t a  pressure 
o f 10- 2  mm and a bath  tem perature o f 40°, then taken up in chloroform  (15 ml) containing 
one equivalent o f triethylam ine(1.4 ml; 1 0  mmoles), subsequently cooled in an ice bath  and 
brought into reaction with phthaloylglycyl chloride b'y dissolution of 2.24 g (10 mmoles) of 
the latter in the reaction mixture. _
An exotherm ic reaction set in. T he next day the  solution was washed with water, 
saturated  sodium  bicarbonate solution, citric acid solution (1%) and again with water. A fter 
drying and evaporation o f the solvent a  crystalline m ass rem ained which was recrystallized 
from  ethyl acetate. Y ield 3.42 (79%), m.p. 173° (very sharp), [a]DZ2° =  —7 .5 ±  1° (c =  0.974 
in M eO H ); TS: R f =  0.61, B e - A n ( l : 1); =  0.84, C H C l3-M eO H  (4 :1 ); =  0.71, system  52.
Analysis: C 2 1 H 2 7 N 3 0 7  Calcd. C 58.19 H  6.28 N  9.70 
(433.45) Found  C 58.2 H  6.3 N  9.9
P h t-G  ly -O rn -O M e . H C l
Selective elimination of the side chain protection in the foregoing dipeptide ester was 
effected by dissolution of 1.3 g (3 mmoles) of the compound in 15 ml o f 1 N-methanolic 
hydrogen chloride. A fter two hours at room  tem perature volatile com ponents o f the solu­
tion were evaporated in vacuo  and the resulting solid ester hydrochloride was recrystallized 
from  m ethanol-ether. Y ield 1.11 g (100%), colourless needles, m elting—after a  phase 
transform ation near 200° —at 225-230° (decomp.); at this tem perature crystals suddenly 
reappeared, and on further heating they m elted sharply at 262°. [a ] D 2 2  =  —16.0 ±  1 ° (c
1.020 in methanol), TS: R f =  0.13 (tailing), C H C l3-M eO H  (4 :1 ); =  0.0, B e-A n  (1 :1 ); =  
0.29, system  52.
A nalysis: C 1 6H 2 0 C lN 3 O 5  Calcd. N  11.36 Cl 9.59 
(369.80) Found  N  11.2 Cl 9.6
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Z -O rn (B o c)-O rn (B o c )-O M e  (V )
5.0 g (13.2 mmoles) o f Z -O rn(B oc)-O M e (II) were hydrogenolyzed in m ethanol (50 ml) 
containing an equivalent am ount o f glacial acetic acid and palladium on charcoal ( 1 0 %). 
A fter filtration and evaporation of the solvent, the residue was dissolved in 10 ml of 
dimethylformamide and 6.57 g (13.9 mmoles) o f Z -O rn(B oc)-O N p ( I I I ) 1 were added. A 
slightly exothermic reaction set in and after 16 hours at room  tem perature the dipeptide 
ester was isolated by dilution with 250 ml o f water, which caused crystallization: 10.3 g of 
crude product were obtained.
This material was purified by crystallization from  a m ixture of 30 ml of boiling m ethanol 
and 25 ml o f water at the sam e tem perature. On cooling slowly to room  tem perature and 
further down to 0°, 7.4 g of the product w ere obtained. This puriflcation was repeated  once 
more to  remove the last traces o f p-nitrophenol. Y ield 7.2 g (93%); M.p. 125°, [a ] D 2 0  =  
-1 5 .1  ± 1 °  ( c =  1.34 in 90% A cO H ). TS: / ï , =  0.71. B e-A n  (1 :1 ); =0.85, chloroform - 
methanol (4:1).
Analysis: C 2 9 H 4GN 4 0 9 Calcd. C 58.85 H 7.72 N  9.63 
(594.69) F ound  C  58.7 H 7 .8  N 9 .4
Z -O rn (B o c)-O rn (B o c)-O rn (B o c)-O rn (B o c)-O M e ( V I I I )
(a) Z -O rn (B o c)-O rn (B o c)-O H  (V I). —8.1 g (13.65 mmoles) o f the protected  dipeptide 
ester (V) were dissolved in 68.2 ml o f pure dioxane and 68.2 ml o f 0.2 ZV-aqueous sodium 
hydroxide were added dropwise with stirring. The m ixture was concentrated to about one 
quarter of its volume and a slightly yellow, but perfectly clear solution was obtained. On 
addition of 15.1 g (13.65 mmoles) o f citric acid a  white pre.cipitate formed, which dissolved 
easily in added ethyl acetate. T he lower layer was replaced by fresh citric acid solution (1 %). 
The organic phase, after extraction, was w ashed with w ater until neutral, dried and evap- 
orated to leave a thick oil, that changed into a  crisp foam on drying in a  high vacuum . Yield,
8.5 g (100%), chromatographically homogeneous. TS: Rt  =  0.03, B e-A n  (1 :1 ); = 0 .2 2 , 
chloroform -m ethanol (4 :1). [a ] D 2 0  =  —3.1 ±  l° (c  =  l , i n  methanol).
(b) H -O rn(B oc)-O rn(B oc)-O M e (V II). —6.4 g (10.8 mmoles) of the sam e ester V , but 
free from p-nitrophenol, were hydrogenolyzed in pure methanol (64 ml) in the presence of 
600 mg of palladium on charcoal (10%). W ithin 5 min. the uptake of hydrogen cam e to  an 
end and slightly more than  the theoretical quantity had been absorbed. T he solution was 
filtered and to the filtrate -  which was free from  any starting material as could be demon- 
strated by thin layer chrom atography — 6.3 g (10.8 mmoles) o f the carboxyl com ponent (VI) 
were added directly to prevent the form ation o f cyclization products.
(c) Z -O rn (B o c)-O rn (B o c)-O rn (B o c)-O rn (B o c)-O M e (V III) .  The m ethanolic solu­
tion as obtained under (b) was evaporated to  dryness and the residue was dissolved in 
dimethylformamide (25 ml). A small am ount o f methanol still present in the solution was 
rem oved in vacuo. In  order to  prevent racem isation in the coupling step, two equivalents 
(2.48 g, 21.6 mmoles) o f N-hydroxysuccinim ide were added 13 to the solution and the mix­
ture was cooled to —20°. Keeping the contents o f the reaction flask at this tem perature, 
2.45 g (21.6 mmoles) of dicyclohexylcarbodiim ide were added to effect coupling. The 
hom ogeneous solution was put in a  refrigerator at —2 0 ° for 6  hours and then at 0 ° for a 
period of 18 hours.
A fter filtration to rem ove dicyclohexylurea, evaporation of the solvent at 0.01 mm, dis- 
solution of the residue in ethyl acetate and filtration to remove a  small am ount o f insoluble 
m aterial, the solution was extracted with w ater (3 x  50 ml), saturated sodium bicarbonate 
solution (3 x  50 ml), 1% citric acid solution (3 X 60 ml) and finally with w ater until neutral
reaction of the aqueous layer. T he resulting solution was dried and evaporated  in vacuo.
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T he product weighed — l i g -  Further-purification was effected by dissolution in methanol 
( 1 0 0  ml) at 60°, follow ed by addition of w ater at the  same tem perature to  insipient cloudi- 
ness. T he slightly turb id  m ixture was allowed to cool down 'to röom  tem perature and the 
protected tetrapeptide ester precipitated in the form  of fine white m icrocrystals. Yield
8.21 g (74%).
N o  useful m aterial could be isolated from the m other liquor. M.p. 152°, chromato- 
graphically hom ogeneous. TS: R t =  0.36, B e-A n  (1 :1 ); =  0.91, chloroform -m ethanol 
(4 :1). [a ] D 2 0  =  —17.8 ±  1° (c =  1 in methanol).
A nalysis: C 4 9 H 8 2 N 8 0 5  Calcd. 57.52 H  8.08 N  10.95 
1023.24 Found  C 57.5 H  8.0 N  10.9
Z -O rn (B o c)-P ro -V a l-G ly -O E t (X lb )
6.5 g (15 mmoles) o f Z -P ro -V a l-G ly -O E t w ere hydrogenolyzed in m ethanol (130 ml) 
containing 4.5 ml o f acetic acid. T he tripeptide ester was isolated as acetate and used as 
such in the next step.
T he salt X, dissolved in 40 ml o f dimethylformamide, was brought into reaction with 
8.78 g (18 mmoles) o f Z -O rn(B oc)-O N p (III) for 16 hours a t room  tem perature. The pro­
duct was isolated by filtration from  some insoluble m aterial, dilution o f the filtrate with 
w ater (four times its original volume), extraction of the turb id  m ixture with ethyl acetate, 
rem oval o f p-nitrophenol from  the extract by washing with sodium  carbonate solution (5%) 
until the w ater layer was virtually free from  this by-product, extraction with citric acid 
solution, then  with w ater until neutral and finally w ith brine, drying with magnesium sulfate, 
concentration to  about 40 ml and dilution with diisopropyl e ther to  250 ml.
T he product separated; it was filtered and washed with the sam e solvent. Further purifica- 
tion was achieved by crystallization from  ethanol/diisopropyl ether. Yield: 8.18 g (84%).
M.p. 125°. TS: / ï / = 0 .4 1 , B e-A n  (1 :1); =  0.84, chloroform -m ethanol (4 :1). [a ] D 2 3  =  
—79.4 ±  1.0° (c =  1 in methanol).
Analysis: C 3 1 H 4 7 N 5 0 9  Calcd. C 59.33 H  7.62 N  10.81 
(647.75) F ound  C  59.5 H 7 .7  N  10.9
Z -O rn (B o c )-P ro -V a l-G ly -O H , (X IIb \ Y  =  O m )
3.14 g (5 mmoles) of the  foregoing protected tetrapeptide ester w ere dissolved in 80 ml 
o f pure dioxane and hydrolyzed by addition of an equivalent am ount o f sodium hydroxide 
in the same volume of w ater (80 ml o f 0.0625 N -N aO H ; 5 mmoles). T he clear yellow solu­
tion was then concentrated  to about half of its volume until a  turbidity appeared. On addi­
tion o f ~ 1 0  mmoles o f citric acid an oil separated but the solution rem ained yellow. 
Extraction of the emulsion with ethyl acetate (2 x  100 ml), o f the  combined extracts Vvith 
citric acid solution and finally with w ater (3 X 100 ml) gave, after drying and evaporation 
o f the solvent, a  residue, that on addition of diisopropyl ether changed into an easily filter- 
able pow der; 3.1 g (100%). T he acid isolated in this way m elted unsharply at 95°. TS: Rf  =  
0.0, B e-A n  (1 :1 ); =  0.13, chloroform -m ethanol (4 :1 ). [a]ó2 2  =  —66.5 ±  1° (c =  1 in m eth­
anol).
Z -Y (B o c )-P ro -V a l-G ly -O rn (B o c)-O rn (B o c)-O rn (B o c )-O rn (B o c )-O M e , ( X l l la  and b)
X l l la ,  Y  =  Lys. N eutral hydrogenolysis of 4.1 g o f the fully pro tected  tetrapeptide ester 
V III (4.0 mmoles) in 50 ml o f methanol, catalysed by 400 mg of palladium on charcoal 
(10%), afforded the free tetrapeptide ester IX  within 30 m inutes, as was confirmed by thin 
layer chromatography: R s — 0.13, B e-A n (1 :1 ) (som ewhat run-out spots); =  0.60, chloro­
454 G . I. Tesser and T. Buis
form -m ethanol (4:1). T he m ethanolic solution was then  evaporated and the residue taken 
up in 10 ml o f dimethylformamide. 0.92 g ( 8  mmoles) o f N-hydroxysuccinim ide and 2.54 
g of Z -L y s(B o c)-P ro -V al-G ly -O H  (X lla ) 1 4  were added and the mixture was stirred 
until a  hom ogeneous solution was obtained. It was cooled to —20° and finally 1.09 g of 
dicyclohexylcarbodiim ide were added. T he flask was kept in a  deep-freezer (at —20°) for 
some hours and then for some days in a  refrigerator at 0°. lts  contents were filtered (0.72 g 
dicyclohexylurea) and the filtrate was concentrated  in a high vacuum  until a  thick turbid
oil remained. This residue could be transform ed into a filterable powder by addition of 
ten  volumes of ether. The weight o f crude product (contam inated with dicyclohexylurea 
only) am ounted to 6.21 g (103%) TS: R f =  0.15, B e-A n  (1 :1 ); =  0.80chloroform -m ethanol 
(4 :1). [a ] D2 2  = —44.8 ±  1.0° (c =  1 in m ethanol). T he octapeptide ester m elted—in this state  
o f purity —in the range of 145-155° and was used as such in the next step (transform ation 
into the amide X I Va).
X lI I b ,  Y  =  O m . This interm ediate was prepared in exactly the same way as described 
for the octapeptide ester containing lysine. Yield: quantitative; melting range: 140-145°. 
TS: i? /= 0 .1 0 , B e-A n  (1 :1 ); =  0.88, chloroform -m ethanol (4 :1). [a ] D 2 2  = —41.0 ±  1.0° 
(c =  1 in methanol).
Z -Y (B o c )-P ro - V al-G ly—O rn(Boc)—O rn(B o c)-O rn (B o c)-O rn (B o c)-N H 2 (X IV a  and b)
X IV a , Y  =  Lys. A fter some prelim inary experim ents the next procedure was adopted 
for the conversion of the octapeptide ester into its amide. The ester X lI Ia  (1.5 g) was 
suspended in a  small am ount o f dry m ethanol and dissolved by addition of a  saturated  solu­
tion o f dry amm onia in the same solvent to  give a  slightly cloudy solution. F o r optimal 
conversion this solution had to be left for three days at room  tem perature. T he solution 
was then  evaporated to dryness; a  gelatinous precipitate was form ed which was taken up 
in ether or diisopropyl ether, F iltration  gave 1.350 g (91%) of crude material. This am ount 
and some pooled fractions obtained in the orienting experim ents. together 2 . 0  g, were 
purified by counter-current distribution in the system  petroleum  ether-ethy l ace ta te - 
m ethanol-w ater (8 :1 6 :9 :6 ) . A fter 153 transfers /-max proved to be 44 and consequently 
K  =  0.41. From  the elem ents 38 -56 , 1.74 g o f pure octapeptide amide were obtained, 
melting a t 202°. TS: R f  =  0.0, B e-A n  (1 :1 ); =  0.85, chloroform -m ethanol (4 :1 ). [a ] D 2 2  =  
—33.2 ±  1.0° (c =  1 in m ethanol)
The amide crystallized with one molecule o f water, which was not rem oved by drying 
over phosphorus pentoxide at 100° and 10- 3  mm pressure for 5 hours.
Analysis: C 7 1 H 1 2 0N 1 4 O2„ Calcd. C 56.56 H  8.16 N  13.01 
(1507.83) F ound  C 56.3 H  8.0 N  13.0
X lV b , Y  =  O m . Aminolysis o f the term inal m ethyl ester function in the pertinent octa­
peptide derivative X lI Ib  was carried out in the sam e way as described for the lysine- 
containing derivative X IV a. T he crude amide was purified by counter-current distribution 
using the same solvent system. In  this case, after 150 transfers rmsx was found to  be 42 
and thus K  =  0.39. F rom  the elem ents 3 2 -5 0  1.34 g o f pure octapeptide amide were 
obtained. A s this synthesis started  with 1.5 g of m ethyl ester, the over-all yield after purifi- 
cation by counter-current distribution am ounted to 90%.
M elting point 198°; [a ] D 22 = —33.0 ±  1.0° (c =  1, in methanol). TS: R f  =  0.0, B e-A n  
(1 :1 ); =  0.90, chloroform -m ethanol (4 :1 ). N one o f these criteria points to a  significant 
distinction betw een the amides X IV a  and X lV b.
This amide also firmly bound one m olecule of water.
14  R . Schwyzer, W. R itte l  a n d /l .  Costopanagiotis, Helv. Chim. A cta45, 2473 (1962).
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A nalysis: C 7 0 H 1 1 8 N 1 4 O 20. H 20  Calcd. C  56.28 H  8.10 N  13.13 
(1493.81) Found C 56.1 H  8.0 N  13.0
Schem e 2.
H -Y (B o c )-P ro -V a l-G ly -O rn (B o c)-O rn (B o c)-O rn (B o c )-O rn (B o c )-N H 2 . H C l, (X'Va 
an d b ).
0.3 mmole of the pro tected  amides X IV a  and b (447 and 443 mg, respectively) were 
each dissolved in pure m ethanol to give a  1% solution. A s neutral hydrogenolysis in the 
presence o f 1 0 0  mg palladium on charcoal (even after filtration o f the catalyst and addition 
of a  fresh am ount o f 100 mg) proved to be impracticably slow, hydrochloric acid (0.3 
mmole) was added to give a  starting concentration of 6  x  10- 3  M. A t regular tim e intervals 
chrom atographic Controls were carried out. Although the starting material had no t com- 
pletely reacted  after 25 h, the reaction had to be interrupted because o f the appearance of 
a  new  spot indicating the  form ation of a rather polar substance. V isual judgem ent of the 
result alforded a conversion o f 90% and the presence of some 10% of this new slowly 
running contam ination.
TS: Rf =  0.85 (starting material, 10%); =  0.76 (amide hydrochloride, 80%); =  0.17 
(newly form ed impurity, 10%), chloroform -m ethanol (4 :1). Both octapeptide amides 
behaved quite analogously. A  small difference in their form ation consisted in the shorter 
reaction tim e (3 h) o f X I Vb, with the concom itant form ation o f som ew hat less Of the slowly 
running side product. Both hydrogenolyses were carried out in duplicate. T he crude amide 
hydrochlorides were used as such in the next step.
B o c -X -T y r-S e r-M e t-G lu (O B u ‘)-H is -P h e -A rg -  T rp -G ly -Y (B o c )-P ro -V a l-G ly -  
O rn (B o c)-O rn (B o c)-O rn (B o c)-O rn (B o c)-N H 2 .A c O H  (X V I I a - d )
T he m ethanolic solutions, obtained by filtering off the catalyst from  th e  suspensions after 
hydrogenolysis, w ere neutralized by addition of 0.3 mmole (0.025 ml) o f pyridine, in order 
to  prevent fu rther breakdow n during evaporation o f the apparently labile amides by resi- 
dual hydrochloric acid. T he solvent was then rem oved from  each o f the four solutions, 
leaving the crude amide hydrochlorides as a thin film in each o f the  vessels. T o  each o f them
T ab le  II
Experim ental data of com pounds a -d
Code n ^max K Yield after ccd. Rf
M d 22  
(c =  0.5 in A cO H )
X V IIa 2 0 0 37 0.23 492 mg (58%) 0.60» -4 9 .0 + 1 .0 °
X V IIb 250 41 0 . 2 0 429 (50%) 0.60*> —3 4 .6 ±  1.0°
X V IIc 280 50 0 . 2 2 284 and 337 mga (73%) 0.60c -3 2 .2  ±1 .0°
X V IId 275 45 0 . 2 0 458 mg (54%) 0.62c -2 5 .3  +  1.0°
'"max is the  maxim um  in the counter-current distribution (ccd) curve after n transfers; K  
is distribution coëfficiënt.
a N o t completely hom ogeneous in thin layer chromatography 
b T S, chloroform -m ethanol (4 :1 ) 
c TS, chloroform -m ethanol (3 :1 )
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10 ml o f dimethylformamide, 524 mg o f the  pertinent protected decapeptide X V Ia  or b 
(0.36 mmole, 20% excess) and 41.4 mg (0.36 mmole) o f /V-hydroxysuccinimide w ere added. 
The m ixtures were stirred to effect dissolution of the decapeptide derivatives, which was 
not possible in both cases where the iV-terminal seryl residue had the D-configuration. 
Finally, 75 mg (0.36 mmole) o f dicyclohexylcarbodiim ide were added to each flask and 
the more or less turbid m ixtures w ere stirred for three days.
T he resulting suspensions were filtered, their clear filtrates concentrated by evaporation 
of the solvent under nitrogen in a  high vacuum  and then taken up in ethyl acetate and fil­
tered. Each of the four crude octadecapeptide amides were purified by counter-current 
distribution in the system  m ethanol-buffer-chloroform -carbon tetrachloride ( 8 : 3 : 6 : 2). 
One litre of buffer solution contained, besides doubly distilled water, 28.5 g of glacial 
acetic acid and 19.25 g of ammonium acetate.
Results are given in the T able II.
Amino acid analyses were carried out on a  sam ple of each of the com pounds o f Table II, 
after hydrolysis with 6  /V-hydrochloric acid (diluted “ Supra-pur” quality from  M erck) for 
24 h at 110°. Results were in accordance with the expected formulae.
[X1, Y 11, O m l-'~ls\-[3-Corticotropin-(] - 1 8 )-octadecapeptide amide (X V III  a - d )
Trifluoroacetic acid (F luka “ purum-quuWly”) was distilled and mixed with w ater (10:1). 
Samples o f each com pound (100 mg) were dissolved in this mixture, taking 2 ml for each 
sample. D issolution took 1 to 2 m inutes, giving slightly yellow solutions. A fter ten  min. at 
room tem perature, the acid was partially evaporated, the residue diluted with w ater and 
again concentrated. This process was repeated twice and the residue was freeze-dried.
Exchange of trifluoroacetate ions by acetate was perform ed in the usual way: a  column 
o f a  weakly basic ion exchanger (M erck II , length 14 cm; diameter 1.5 cm) in the acetate 
cycle was loaded with an aqueous solution of the lyophilized product (~  10 ml). A fter the 
solution had entered, the column was washed with doubly distilled water. T he filtrate was 
collected as long as the Fo lin -C iocalteux  reaction was positive and the product was 
isolated by freeze-drying.
In each case nearly 80 mg of white foam was obtained which represented the end- 
product. Prior to  weighing, the samples w ere dried over P 2 0 5 at a  pressure of 10- 2  mm, so 
the yields o f this last step approach 1 0 0 %.
Chrom atographic exam ination of the end-products revealed the absence o f oxidized 
m ethionyl functions in the tw o analogues D  and E. T he analogues B and C , however, were 
contam inated with some m aterial that contained sulphoxide ( 1 0  and 2 0 %, respectively). 
In the estim ation o f biological activity no allowance was made for the presence of these 
contam inants. T he oxidation was probably caused by the occurrence of traceè of peroxide 
in the acetic acid, that was incorporated in the buffer of the solvent system  used for counter- 
current distributions: On catalytic hydrogenation of a whole litre of A .R. glacial acetic acid 
75 ml of hydrogen (3 mmoles) w ere taken up.
H ydrogenation of acetic acid is an effective m eans of elimination of peroxides and is 
therefore strongly recommended.
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